Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftriaxone for pain and inflammation after knee arthroscopy
NCT05149287Phase 2Terminated
- Start
- Dec 2021
- Primary completion
- Apr 2022
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ceftriaxone in postoperative pain and post-operative inflammation (2 arms). Primary endpoints: Visual Analog Scale at 2 months, RU SATED at 2 months and 1 more. Started Dec 2021; status: terminated.
02
Drugs
ceftriaxone
03
Conditions
postoperative painpost-operative inflammation
Beyond the preview
Go deeper on NCT05149287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05149287.